Health Science Policy Council Chair 2019 - 2021
Shelby Reed, RPh PhD
Professor, Duke Clinical Research Institute
Durham, NC, United States
Health Science Policy Council Members
Policy Outlook Committee
Ola Ahmad Al Ahdab, RPh PhD BSc
Dr
Abu Dhabi, AZ, United Arab Emirates
Pamela Blumberg, DrPH MPH
Cambridge, MA, United States
Lou Garrison, PhD
Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute,
Seattle, WA, United States
Jorge Gómez, MSc PhD
Senior HE Manager for Vaccines LATAM, GlaxoSmithKline
Victoria, B, Argentina
Jens Grueger, PhD
Director and Partner, Boston Consulting Group
Freiburg, BW, Germany
Finn Børlum Kristensen, PhD MD
Managing Director, Science & Policy
Hilleroed, Denmark
Eui-Kyung Lee, RPh PhD
sungkyunkwan university
Taipei, Taiwan
Newell Mcelwee, PharmD MSPH
Vice President HEOR, Boehringer Ingleheim
Ridgefield, CT, United States
Maciej Niewada, MSc PhD MD MA
Professor, ISPOR Poland Chapter
Warsaw, MZ, Poland
Brian O'Rourke, PharmD
CADTH President & CEO, CADTH
Ottawa, ON, Canada
Chris Pashos, BS PhD MPP
VP, Global Evidence Strategy, Abbvie
North Chicago, IL, United States
Suzanne Schrandt, JD
Founder, CEO, & Chief Patient Advocate, ExPPect
Washington, DC, United States
Redouane Soualmi, MSc PharmD
Head of Market Access & Government Affairs, Boehringer Ingelheim
Ouled Fayet, 16, Algeria
Adrian Towse, Mphil MA
Director, Office of Health Economics
London, United Kingdom
Science/Research Committee
Ibrahim Alabbadi, MBA RPh PhD DrPH BSc
Professor, The University of Jordan
Amman, AM, Jordan
Michael Drummond, PhD
Professor of Health Economics, University of York
Lichfield, STS, United Kingdom
Ana Lucia Hincapie, MSc PhD
Assistant Professor, University of Cincinnati College of Pharmacy
CINCINNATI, OH, United States
Rok Hren, MSc PhD BSc
Director, Hren & Partner d.o.o.
Ljubljana, Slovenia
Maarten IJzerman, MSc PhD
Chair of Cancer Health Services Research, University of Melbourne and University of Twente
Melbourne, VIC, Australia
Khalid Kamal, MS PhD
Professor, Duquesne University
McDonald, PA, United States
Paul Kind
Professor, University of Leeds
Leeds, United Kingdom
Vivian Lee, PharmD BSc
Associate Professor, The Chinese University of Hong Kong
Shatin, Hong Kong
Josephine Mauskopf, PhD
Vice President, Health Economics, RTI Health Solutions
Research Triangle Park, NC, United States
Karen Rascati, RPh PhD
Professor, University of Texas College of Pharmacy
Austin, TX, United States
Shelby Reed, RPh PhD
Professor, Duke Clinical Research Institute
Durham, NC, United States
Mark Sculpher, MSc PhD BA
University of York
York, NYK, United Kingdom
Marthinus Stander, MBA MD
Managing Director, VI Research FZ-LLC
Dubai, DU, United Arab Emirates
Task Force Review Committee
Federico Augustovski, MSc PhD MD
Director, HTA, (IECS) Institute for Clinical Effectiveness and Health Policy
Buenos Aires, Argentina
Marc Berger, MD
Marc L. Berger, LLC
New York, NY, United States
Reed Johnson, PhD
Professor, Duke School of Medicine, Duke Clinical Research Institute
Durham, NC, United States
C. Daniel Mullins, PhD
Professor, University of Maryland School of Pharmacy
Baltimore, MD, United States
Donald Patrick, PhD MSPH
Professor and Associate Chair, University of Washington
Seattle, WA, United States
Scott Ramsey, PhD MD
Full Member & Co-Director, Fred Hutchinson Cancer Research Center
Seattle, WA, United States
Mark S. Roberts, MD MPP
Professor and Chair, Health Policy and Management, University of Pittsburgh
Pittsburgh, PA, United States